Walmart to alter opioid prescription policies at its pharmacies
Date: 2018-05-08   Author: Ojaswita Kutepatil  Category: #news

Walmart to alter opioid prescription policies at its pharmacies

In a bid to curb opioid misuse and abuse, Walmart Inc., has announced that it will only fill first-time opioid prescriptions for acute pain to seven days or even less across the United States. Reportedly, the initiative will be commenced within 60 days and comes on the heels of the rising number of healthcare entities tightening the rules surrounding the filing of opioid prescriptions.

Sources reveal that pharmacies, beginning 1st January 2020, will be restricting the dosage of opioids to not more than 50 MMEs (morphine milligrams equivalent) per day and will require online prescriptions for controlled substances. The e-prescriptions are deemed to minimize error and prevent prescription frauds.  

Marybeth Hays, Walmart’s executive VP of health and wellness and consumables, was quoted stating that the company is taking action in the fight against the nation’s opioid epidemic. In an effort to continue to be a part of the solution, Walmart is introducing new programs, tools and policies that will be aimed at addressing the critical issues faced by the patients & communities.

Reliable reports claim that the initiatives will also be applicable to Sam’s Club Pharmacies, which is owned by Walmart. Several other companies have also been making similar efforts to help mitigate the opioid epidemic.

As per industry analysts, these proposals have disclosed that limitations are important to lower the number of painkillers that are available to be unlawfully diverted, stem overprescribing, and lower the potential for addiction.

Opioid overdose crisis and the proposal for its limits have garnered significant support from several shareholders, owing to which a bill in the Senate will be restricting the initial prescriptions for acute pain to 3 days.

Meanwhile, the AMA (American Medical Association) has countered that the limits over opioid dosage & supply are arbitrary and believes that the decision needs to be left between the physician and the patient.



About Author


Ojaswita Kutepatil

Ojaswita Kutepatil

Ojaswita Kutepatil, a mechanical engineer by qualification, worked as a BDE and Technical Engineer before switching her profession to content writing. Currently, she works at AlgosOnline. as an Content writer, where she pens down write-ups pertaining to the market res...

Read More

More from Ojaswita


Post Recommendents

Food/Pharmaceutical Peony Market Size - Industry Analysis, Share, Growth, Trends, and Forecast 2019-2025
Author: Partha Ray

MarketStudyReport.com presents the Food/Pharmaceutical Peony Market report that provides a detailed overview of major drivers, restraints, challenges, opportunities, current industry trends and strategies impacting the global market along with est...


Oilfield Service Market Size, Development, Key Opportunity, Application and Forecast to 2025
Author: Partha Ray

This report on Oilfield Service market Added by Market Study Report, LLC, covers valuable insights based on market valuation, market size, revenue forecast, SWOT Analysis and regional outlook of this industry. The research also presents a precise ...


Fuel Injection Systems Market Size, Growth, Analysis, Outlook by 2019 - Trends, Opportunities and Forecast to 2025
Author: Partha Ray

The research report on Global Fuel Injection Systems Market provides up-to-date industry trends, the present market scenario, and the market forecast during 2018-2023. The complete analysis of Fuel Injection Systems market on the global scale prov...